<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05020756</url>
  </required_header>
  <id_info>
    <org_study_id>Blend 002</org_study_id>
    <nct_id>NCT05020756</nct_id>
  </id_info>
  <brief_title>Study in Children Who Have Switched to Isosource Junior Mix Formula</brief_title>
  <official_title>A Retrospective Study In Children Who Have Switched to Isosource Junior Mix Formula (RICIMIX Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Great Ormond Street Hospital for Children NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Retrospective study In Children who have switched to Isosource Junior Mix formula (RICIMIX&#xD;
      study) will review paediatric children &gt; 12 months of age who require Isosource Junior Mix as&#xD;
      an enteral tube feeding formula and have consumed the formula for at least 1 month. The&#xD;
      purpose of this study is to understand If there has been an improvement in outcomes/&#xD;
      experiences&#xD;
&#xD;
        -  The current usage of ISJMIX formula in children who require blended diets&#xD;
&#xD;
        -  Improved feeding intolerances&#xD;
&#xD;
        -  Improved patient outcomes/ experiences&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective data will be collected using questionnaire by the dietitians at the nutrition&#xD;
      and dietetic department. All completed questionnaires will be sent back to Nestle Health&#xD;
      Science/ CRO company.&#xD;
&#xD;
      The primary objectives:&#xD;
&#xD;
      The following measures will be collected retrospectively after 1 month use of ISJMIX&#xD;
&#xD;
        -  Feeding tolerance [no change, tolerance improved, tolerance worsened]: gastric&#xD;
           residuals, gagging/retching, vomiting, abdominal distention/ gas, stool consistency&#xD;
           issues (too hard, too loose)&#xD;
&#xD;
        -  Volume of formula consumed in a day&#xD;
&#xD;
      The secondary objective is to collect restropective data on:&#xD;
&#xD;
        -  Any improved patient outcomes noted&#xD;
&#xD;
        -  Calculate the potential cost savings made when using ISJMIX to help manage the feeding&#xD;
           intolerances&#xD;
&#xD;
        -  Calculate the potential costs benefit of using ISJMIX over other standard formulas&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 26, 2021</start_date>
  <completion_date type="Actual">August 2, 2021</completion_date>
  <primary_completion_date type="Actual">March 26, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Feeding tolerance</measure>
    <time_frame>30 days</time_frame>
    <description>The following measures will be collected retrospectively after 1 month use of ISJMIX&#xD;
• Feeding tolerance [no change, tolerance improved, tolerance worsened]: gastric residuals, gagging/retching, vomiting, abdominal distention/ gas, stool consistency issues (too hard, too loose)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volume consumed</measure>
    <time_frame>30 days</time_frame>
    <description>Average volume consumed over month period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight in Kg</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">43</enrollment>
  <condition>Cerebral Palsy</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Isosource Junior Mix</intervention_name>
    <description>Single arm study, collecting data on those who have been on Isosourcr Junior mix tube feed formula for 30 days</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Paediatric children &gt; 12 months of age who require Isosource Junior Mix as an enteral tube&#xD;
        feeding formula and have consumed the formula for at least 1 month&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All children who are using Isosource Junior Mix as tube feed formula&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  All children who did not switch to Isosource Junior Mix feed formula&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nestle Health Science</name>
      <address>
        <city>Gatwick</city>
        <zip>RH6 0PA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 28, 2021</study_first_submitted>
  <study_first_submitted_qc>August 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

